SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of SQZ Biotechnologies Co?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SQZ Biotechnologies Co market cap is $825,800.00.
What is the 52-week high for SQZ Biotechnologies Co?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SQZ Biotechnologies Co 52 week high is $0.07 as of September 12, 2025.
What is the 52-week low for SQZ Biotechnologies Co?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SQZ Biotechnologies Co 52 week low is $0.023 as of September 12, 2025.
What is SQZ Biotechnologies Co stock price today?
SQZ Biotechnologies Co stock price today is $0.028.
What was SQZ Biotechnologies Co stock price yesterday?
SQZ Biotechnologies Co stock price yesterday was $0.028.
What is the 50-day moving average of SQZ Biotechnologies Co?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. SQZ Biotechnologies Co 50-day moving average is $0.028.